|
Index of reports
> Cases resulting in hospitalization (298)
> Cases with Pyrexia (34)
Below is the selection of adverse event reports related to Cytarabine that includes cases resulting in hospitalization where reactions include pyrexia.
Reports 1 - 25 of 34 Next >>
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male, weighing 62.9 kg (138.4 pounds)
Adverse reactions / side effects: Gastrointestinal Necrosis, Pyrexia, Constipation, Faecaloma, Gastritis, Oesophageal Candidiasis, Inappropriate Antidiuretic Hormone Secretion, Colitis, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 172 mg
Methotrexate
Dosage: 30 mg
PEG-L-Asparaginase (K-H)
Dosage: 4300 iu
Prednisone TAB
Dosage: 2800 mg
Vincristine Sulfate
Dosage: 8 mg
Adverse event in 72 year old female receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 72 year old female
Adverse reactions / side effects: Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Indication: Acute Myeloid Leukaemia
End date: 2007-07-07
Cytarabine
Dosage: 100 mg iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-08-08
End date: 2007-08-13
Other drugs received by patient: Darvocet; Levaquin; Magnesium; Micro-K; Protonix; Valtrex
Adverse event in receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient:
Adverse reactions / side effects: Respiratory Rate Increased, Febrile Neutropenia, Headache, Pyrexia, Balance Disorder, Blood Culture Positive, Heart Rate Increased, Dizziness, Bacterial Infection, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 1700 mg
Start date: 2006-12-12
End date: 2007-07-02
Cytarabine
Dosage: 10200 mg
End date: 2007-07-05
G-Csf(filgrastin, Amgen)(614629)
Dosage: 3000 mcg
End date: 2007-07-17
L-Asparaginase(109229)
Dosage: 10000 unit
End date: 2007-07-16
Methotrexate
Dosage: 15 mg
End date: 2007-07-02
Adverse event in 58 year old male receiving Cytarabine
Reported by a physician from France on 2007-10-02
Patient: 58 year old male, weighing 83.0 kg (182.6 pounds)
Adverse reactions / side effects: Agranulocytosis, Renal Failure, Hypotension, Pyrexia, Septic Shock, Aplasia, Escherichia Sepsis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Cytarabine
Dosage: 3gx2/d
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-08-07
End date: 2007-08-08
Imatinib
Dosage: 400 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-08-06
End date: 2007-08-15
MTX
Dosage: 2g/d
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-08-06
End date: 2007-08-06
Other drugs received by patient: Novolog MIX 70 / 30; Zelitrex; Nexium; Metformin HCL
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-07-25
Patient: female, weighing 57.6 kg (126.7 pounds)
Adverse reactions / side effects: Tachycardia, Pyrexia, Pupils Unequal, Cerebral Haemorrhage, Dialysis, Blood Culture Positive, Acute Respiratory Distress Syndrome, Hypoxia, Pleural Effusion, Blood Creatinine Increased, Lung Injury, White Blood Cell Count Decreased, Fluid Overload, Dyspnoea, Alanine Aminotransferase Increased, Hypotension, General Physical Health Deterioration, Alpha Haemolytic Streptococcal Infection, Aspartate Aminotransferase Increased, Neutropenia, Bradycardia, Lung Infiltration
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 1127 mg
Daunorubicin HCL
Dosage: 216 mg
Mylotarg
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-07-23
Patient: female, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Chromaturia, Pyrexia, Hypokalaemia, Haemoglobin Decreased, Oral Pain, Pharyngolaryngeal Pain, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 3000 mg
Etoposide
Ifosfamide
Leucovorin Calcium
Mesna
Methotrexate
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Vincristine Sulfate
Other drugs received by patient: Neupogen
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-07-16
Patient: female, weighing 24.0 kg (52.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Renal Infarct, Tachycardia, Pyrexia, Renal Vein Embolism, Haematoma, Pyelonephritis, Bronchopulmonary Aspergillosis, Haematuria, Malnutrition, Pancytopenia, Blood Fibrinogen Increased, Urinary Tract Obstruction, Fungal Infection, Neutropenia, Renal Embolism, Neutrophil Count Decreased, Rash Maculo-Papular, Renal Necrosis, Systemic Mycosis, Abdominal Pain Upper, Blood Calcium Decreased, Hepatomegaly, Laboratory Test Abnormal, Tachypnoea, Abdominal Distension, Pleural Effusion, Breath Sounds Absent, Splenomegaly, Sinusitis, Oxygen Saturation Decreased, Fluid Overload, White Blood Cell Count Decreased, Kidney Enlargement, Lung Neoplasm, Flank Pain, Hypoalbuminaemia, Aspergillosis, Liver Abscess, Psoas Sign, Inflammation
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 7030 mg
Mitoxantrone HCL
Dosage: 40 mg
Adverse event in 18 year old male receiving Cytarabine
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-13
Patient: 18 year old male
Adverse reactions / side effects: Brain Abscess, Arthritis Bacterial, Pyrexia, Altered State of Consciousness, Aplasia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 52 mg qd iv
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Adverse event in 59 year old female receiving Cytarabine
Reported by a pharmacist from United States on 2007-07-12
Patient: 59 year old female
Adverse reactions / side effects: Pyrexia, Cardiomyopathy, Cardiac Failure Congestive, Leukopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 6g q12 iv
Indication: Acute Myeloid Leukaemia
Start date: 2006-02-06
End date: 2006-02-08
Daunorubicin Unknown
Dosage: unknown
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Lasix; Docusate; Gabapentin; Heparin; Insulin; Isosorbide Dinitrate; Lisinopril; Lopressor; Zofran; Protonix; Aldactone; Effexor; Ambien
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-07-05
Patient: male, weighing 109.0 kg (239.8 pounds)
Adverse reactions / side effects: Mucosal Inflammation, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 2330 mg
Cytarabine
Dosage: 40 mg
Dexamethasone 0.5mg TAB
Dosage: 120 mg
Leucovorin Calcium
Dosage: 7689 mg
Methotrexate
Dosage: 3494 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 874 mg
Vincrisitne Sulfate
Dosage: 2 mg
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-06-25
Patient: male, weighing 20.2 kg (44.4 pounds)
Adverse reactions / side effects: Blood Albumin Decreased, Pyrexia, Haematocrit Decreased, Refusal of Treatment by Relative, White Blood Cell Count Decreased, Vomiting, Skin Graft, Blood Potassium Increased, Pulmonary Haemorrhage, Haemoglobin Decreased, NO Therapeutic Response, Platelet Count Decreased, Neutropenia, Bradycardia, Cardiac Arrest, Blood Pressure Decreased, Escherichia Infection, Lung Infiltration, Wound Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 850 mg
Cytarabine
Dosage: 30048 mg
Etoposide
Dosage: 510 mg
G-CSF (Filgrastim, Amgen)
Dosage: 2500 mg
Hydrocortisone
Dosage: 24 mg
Leucovorin Calcium
Dosage: 78 mg
Mercaptopurine
Dosage: 225 mg
Mesna
Dosage: 170 mg
Methotrexate
Dosage: 8475 mg
PEG-L Asparaginase (K-H)
Dosage: 6250 unit
Adverse event in female receiving Cytarabine
Reported by a physician from Finland on 2007-06-14
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Weight Decreased, Nasopharyngitis, Blood Albumin Decreased, Pyrexia, Diplopia, Fatigue, Immunoglobulins Decreased, Pitting Oedema, Decubitus Ulcer, Balance Disorder, C-Reactive Protein Increased, CD4 Lymphocytes Decreased, Nausea, Anxiety, Affective Disorder, Haemoglobin Decreased, Communication Disorder, Vertigo, Memory Impairment, Progressive Multifocal Leukoencephalopathy, Ossicle Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Cyclophosphamide
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Cytarabine
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Oncovin
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Prednisone TAB
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Trexan
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-06-14
Patient: male, weighing 85.4 kg (187.9 pounds)
Adverse reactions / side effects: Atelectasis, Tachycardia, Pyrexia, Nephrolithiasis, Hepatomegaly, Blood Culture Positive, Pleural Effusion, Sputum Culture Positive, Renal Failure Acute, Hypotension, Atrial Fibrillation, Ascites, Haemodialysis, Cholelithiasis, Staphylococcal Infection, Sepsis, Ejection Fraction Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 3760 mg
Start date: 2007-05-22
Dexamethasone 0.5mg TAB
Dosage: 80 mg
Ifosfamide
Dosage: 7500 mg
Leucovorin Calcium
Dosage: 475 mg
Mesna
Dosage: 3800 mg
Methotrexate
Dosage: 2820 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 705 mg
Vincristine Sulfate
Dosage: 2 mg
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-06-12
Patient: , weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Vomiting, Diarrhoea, Blood Culture Positive, Circulatory Collapse, Pyrexia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Cytarabine
Dosage: 150 mg (100mg/m2); cummulative dose = 2550 mg
Indication: Acute Myeloid Leukaemia
Start date: 2006-12-07
End date: 2007-03-19
Etoposide
Dosage: 150 mg; cummulative dose = 1350 mg
Indication: Acute Myeloid Leukaemia
Start date: 2006-12-07
End date: 2007-03-17
Gemtuzumab Ozogamicin
Dosage: unknown
Start date: 2007-03-14
Idarubicin HCL
Dosage: 10 mg; cummulative dose = 60 mg
Indication: Acute Myeloid Leukaemia
Start date: 2007-01-20
End date: 2007-03-19
Other drugs received by patient: Ondansetron; Acyclovir; Sertraline
Adverse event in female receiving Cytarabine
Reported by a physician from Finland on 2007-06-08
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Weight Decreased, Nasopharyngitis, Blood Albumin Decreased, Pyrexia, Diplopia, Fatigue, Immunoglobulins Decreased, Pitting Oedema, Decubitus Ulcer, Balance Disorder, C-Reactive Protein Increased, CD4 Lymphocytes Decreased, Nausea, Anxiety, Affective Disorder, Haemoglobin Decreased, Communication Disorder, Vertigo, Memory Impairment, Progressive Multifocal Leukoencephalopathy, Ossicle Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Cyclophosphamide
Dosage: text:oral
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Cytarabine
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-10-04
Oncovin
Indication: Burkitt's Lymphoma
Start date: 2006-06-01
End date: 2006-09-11
Prednisone TAB
Indication: Burkitt's Lymphoma
Trexan
Indication: Burkitt's Lymphoma
Adverse event in 48 year old male receiving Cytarabine
Reported by a pharmacist from United States on 2007-05-24
Patient: 48 year old male
Adverse reactions / side effects: Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Other drugs received by patient: Filgrastim
Adverse event in 55 year old female receiving Cytarabine
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-15
Patient: 55 year old female, weighing 84.0 kg (184.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Haemoglobin Decreased, Haematocrit Decreased, Platelet Count Decreased, Febrile Neutropenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Start date: 2007-04-05
End date: 2007-04-09
Etoposide
Start date: 2007-04-05
End date: 2007-04-09
Novantrone
Indication: Acute Myeloid Leukaemia
Start date: 2007-04-05
End date: 2007-04-09
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-05-10
Patient: male, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Pulmonary Hypertension, Lymphadenopathy, Pancytopenia, Pyrexia, Treatment Noncompliance, Disease Progression, Mucosal Inflammation, Lung Disorder, Epistaxis
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: 2000 mg
Start date: 2007-04-18
Cytarabine
Dosage: 40 mg it therapy
Doxorubicin Hydrochloride
Dosage: 100 mg
Leucovorin Calcium
Dosage: 130 mg
Methotrexate
Dosage: 1030 mg
Start date: 2007-04-18
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 800 mg
Vincristine Sulfate
Dosage: 2 mg
Adverse event in 74 year old male receiving Cytarabine
Reported by a physician from France on 2007-05-07
Patient: 74 year old male, weighing 71.0 kg (156.2 pounds)
Adverse reactions / side effects: Dysuria, Pyrexia, Escherichia Infection, Hydrocele
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 17.80 mg, intravenous
Indication: Myelodysplastic Syndrome
Start date: 2006-12-29
End date: 2007-01-11
Velcade
Dosage: 1.78 mg, intravenous
Indication: Myelodysplastic Syndrome
Start date: 2006-12-29
End date: 2007-01-09
Adverse event in 23 year old female receiving Cytarabine
Reported by a physician from United States on 2007-05-04
Patient: 23 year old female, weighing 78.7 kg (173.2 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Chapped Lips, Extrasystoles, Headache, Pyrexia, Erythema, Hyperhidrosis, Abdominal Tenderness, Activated Partial Thromboplastin Time Prolonged, Fibrin D Dimer Increased, Ecchymosis, Hypomagnesaemia, Sedation, Alkalosis, Nervousness, Proctalgia, Pancytopenia, Breath Sounds Abnormal, Aspartate Aminotransferase Increased, Septic Shock, Pulse Abnormal, Chills, Petechiae, Hypokalaemia, Photophobia, Renal Failure Acute, Vomiting, Nausea, International Normalised Ratio Increased, Alanine Aminotransferase Increased, Skin Disorder, Atrial Fibrillation, Hypophosphataemia, Diarrhoea, Ejection Fraction Decreased, Escherichia Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 40 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-03-19
End date: 2007-03-23
Cytarabine
Dosage: 2000 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-03-19
End date: 2007-03-23
Other drugs received by patient: Ondansetron; Acetaminophen; Diphenhydramine HCL; Hydrocortisone; Lorazepam; Prednisolone; Artificial Tears; Emend; Avelox; Acyclovir; Diflucan; Lexapro; Depo-Provera; Ambien; Zyrtec; Oxycodone HCL; Xanax; Prednisone TAB; Triamcinolone; Micro-K; Magnesium Oxide
Adverse event in 74 year old male receiving Cytarabine
Reported by a physician from France on 2007-04-26
Patient: 74 year old male, weighing 71.0 kg (156.2 pounds)
Adverse reactions / side effects: Dysuria, Pyrexia, Escherichia Infection, Hydrocele
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 17.80 mg, intravenous
Indication: Myelodysplastic Syndrome
Start date: 2006-12-29
End date: 2007-01-11
Velcade
Dosage: 1.78 mg, intravenous
Indication: Myelodysplastic Syndrome
Start date: 2006-12-29
End date: 2007-01-09
Adverse event in 28 year old male receiving Cytarabine
Reported by a individual with unspecified qualification from Japan on 2007-04-24
Patient: 28 year old male
Adverse reactions / side effects: Hepatic Function Abnormal, Stomatitis, Anaemia, Chills, Condition Aggravated, Headache, Pyrexia, Skin Ulcer, Diarrhoea, Sepsis, Acute Respiratory Distress Syndrome, Platelet Count Decreased, Neutrophil Count Decreased, Mucous Membrane Disorder, Epistaxis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cytarabine
Dosage: intravenous (not otherwise specified); intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-06-10
End date: 2006-06-16
Cytarabine
Dosage: intravenous (not otherwise specified); intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-08-14
End date: 2006-08-18
Idarubicin HCL
Dosage: intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-06-10
End date: 2006-06-16
Mylotarg
Dosage: 6 mg/m2, 1 in 1 days, intravenous (not otherwise specified); intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-06-09
End date: 2006-06-09
Mylotarg
Dosage: 6 mg/m2, 1 in 1 days, intravenous (not otherwise specified); intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-06-23
End date: 2006-06-23
Novantrone
Dosage: intravenous (not otherwise specified)
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2006-08-14
End date: 2006-08-16
Other drugs received by patient: Granisetron; Hydrocortisone Sodium Succinate; Heparin-Fraction, Sodium Salt; Itraconazole; Famotidine; Teprenone; Bactrim; Polymyxin B Sulfate; Monoamnonium Glycyrrhizinate / Glycine / L-Cysteine (Glycyrrhizic Acid, AM; Chlorpheniramine Maleate; Acetaminophen; Hydrocortisone Sodium Succinate; Dipyridamole
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-04-23
Patient: female, weighing 25.5 kg (56.1 pounds)
Adverse reactions / side effects: Fluid Overload, Disseminated Intravascular Coagulation, Hypotension, Tachycardia, Hepatic Failure, Pyrexia, Abdominal Tenderness, Ascites, Renal Failure, Alpha Haemolytic Streptococcal Infection, Left Ventricular Dysfunction, Tachypnoea, Neutrophil Count Decreased, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 7840 mg
Mylotarg
Dosage: 2.9 mg
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-04-17
Patient: , weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Vomiting, Diarrhoea, Blood Culture Positive, Circulatory Collapse, Pyrexia, Shock
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Cytarabine
Dosage: 150 mg; cummulative dose = 2250 mg
Indication: Acute Myeloid Leukaemia
Start date: 2006-12-07
End date: 2007-03-19
Etoposide
Dosage: 150 mg; cummulative dose = 1350 mg
Indication: Acute Myeloid Leukaemia
Start date: 2006-12-07
End date: 2007-03-17
Gemtuzumab Ozogamicin
Dosage: unknown
Idarubicin HCL
Dosage: 10 mg; cummulative dose = 60 mg
Indication: Acute Myeloid Leukaemia
Start date: 2007-01-20
End date: 2007-03-20
Other drugs received by patient: Ondansetron; Acyclovir; Sertraline
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-04-05
Patient:
Adverse reactions / side effects: Vomiting, Diarrhoea, Blood Culture Positive, Hypotension, Circulatory Collapse, Pyrexia, Anuria
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cytarabine
Dosage: unknown
Etoposide
Dosage: unknown
Gemtuzumab Ozogamicin
Dosage: unknown
Idarubicin HCL
Dosage: unknown
Page 1 Next >>
|
